Sie befinden sind hier: Startseite > Börse > Unternehmensnachrichten > Endospan Artivion, Inc. Israel

ENDOSPAN, RECEIVES

ENDOSPAN RECEIVES ADDITIONAL $25M FROM ARTIVION FOR NEXUS FDA APPROVAL PATH

07.08.2025 - 18:04:31

Endospan Artivion, Inc. Israel

View original content:https://www.prnewswire.co.uk/news-releases/endospan-receives-additional-25m-from-artivion-for-nexus-fda-approval-path-302188027.html

@ prnewswire.co.uk | DE0005220909 ENDOSPAN